PUBLISHER: 360iResearch | PRODUCT CODE: 1600142
PUBLISHER: 360iResearch | PRODUCT CODE: 1600142
Marine Derived Drugs Market by Source (Algae, Invertebrates, Microorganisms), Drug Type (Analgesics, Anti-coagulants, Anti-inflammatory), End-User - Global Forecast 2025-2030
The Marine Derived Drugs Market was valued at USD 4.10 billion in 2023, expected to reach USD 4.44 billion in 2024, and is projected to grow at a CAGR of 8.70%, to USD 7.36 billion by 2030.
Marine-derived drugs refer to pharmaceuticals that are extracted or synthesized from marine organisms, such as algae, bacteria, fungi, sponges, and mollusks. The scope of these drugs encompasses a wide range of therapeutic applications, including treatments for cancer, infections, cardiovascular diseases, and inflammation. The necessity for marine-derived drugs is driven by their unique bioactive compounds, which often offer novel mechanisms of action not found in terrestrial organisms. These drugs are applied in both pharmaceutical and biotechnology settings, with end-use scope including hospitals, research institutions, and pharmaceutical manufacturers.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 4.10 billion |
| Estimated Year [2024] | USD 4.44 billion |
| Forecast Year [2030] | USD 7.36 billion |
| CAGR (%) | 8.70% |
The market for marine-derived drugs is influenced by factors such as technological advancements in marine biotechnology, increased funding for marine biodiversity research, and a surge in demand for novel therapeutics. The rising incidence of chronic diseases and the growing awareness of the benefits of marine bioproducts further bolster market growth. Recent opportunities lie in the in-depth exploration of uncharted marine habitats, fostering collaborations partnerships between academia and industry, and the development of sustainable harvesting techniques. However, challenges include stringent regulatory frameworks, high research and development costs, and uncertainties related to environmental conservation efforts. There's a need for regulatory bodies to streamline processes and promote sustainable practices, aligning conservation efforts with pharmaceutical development.
Innovation opportunities abound in areas such as bioprospecting for undiscovered marine organisms, the improvement of drug delivery systems, and the synthesis of marine-inspired analogs. Insightful research can focus on genomics and metabolomics to unravel complex marine biosystems, advancing the potential for groundbreaking drug discoveries. The nature of the market is highly dynamic, driven by a combination of scientific inquiry and commercial viability. Companies aiming to grow in this space should invest in cross-disciplinary research, leverage artificial intelligence for data analysis, and engage in global collaborations to overcome limitations and maximize the expertise required in the field.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Marine Derived Drugs Market
The Marine Derived Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Increasing prevalence of chronic diseases worldwide
- Growing investments in marine biotechnologies by government and private authorities
- Market Restraints
- High cost of development of new drugs associated with marine sources
- Market Opportunities
- Increasing advances in extraction and synthesis technologies of marine derived drugs
- Growing focus on expanding therapeutic potential of marine-derived drugs
- Market Challenges
- Environmental and ethical concerns with marine derived drugs
Porter's Five Forces: A Strategic Tool for Navigating the Marine Derived Drugs Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Marine Derived Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Marine Derived Drugs Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Marine Derived Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Marine Derived Drugs Market
A detailed market share analysis in the Marine Derived Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Marine Derived Drugs Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Marine Derived Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Marine Derived Drugs Market
A strategic analysis of the Marine Derived Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Marine Derived Drugs Market, highlighting leading vendors and their innovative profiles. These include Aker BioMarine ASA, Aphios Corporation, Eisai Co., Ltd., Gimv NV, GlycoMar Limited, Marinova Pty Ltd., Nereus Pharmaceuticals, Inc., Perha Pharmaceuticals, Pfizer, Inc., Pharma Mar, S.A., TransAlgae, and Zelnova Zeltia.
Market Segmentation & Coverage
This research report categorizes the Marine Derived Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Source, market is studied across Algae, Invertebrates, and Microorganisms.
- Based on Drug Type, market is studied across Analgesics, Anti-coagulants, Anti-inflammatory, Anti-microbial, Anti-viral, and Anticancer.
- Based on End-User, market is studied across Hospitals, Pharmaceutical & Biotechnology Companies, and Research & Academic Institutions.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing prevalence of chronic diseases worldwide
- 5.1.1.2. Growing investments in marine biotechnologies by government and private authorities
- 5.1.2. Restraints
- 5.1.2.1. High cost of development of new drugs associated with marine sources
- 5.1.3. Opportunities
- 5.1.3.1. Increasing advances in extraction and synthesis technologies of marine derived drugs
- 5.1.3.2. Growing focus on expanding therapeutic potential of marine-derived drugs
- 5.1.4. Challenges
- 5.1.4.1. Environmental and ethical concerns with marine derived drugs
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.2.1. Source: Growing usage of algae especially in skincare products
- 5.2.2. End-User: High potential of marine derived drugs across hospitals that have obtained regulatory approvals
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Marine Derived Drugs Market, by Source
- 6.1. Introduction
- 6.2. Algae
- 6.3. Invertebrates
- 6.4. Microorganisms
7. Marine Derived Drugs Market, by Drug Type
- 7.1. Introduction
- 7.2. Analgesics
- 7.3. Anti-coagulants
- 7.4. Anti-inflammatory
- 7.5. Anti-microbial
- 7.6. Anti-viral
- 7.7. Anticancer
8. Marine Derived Drugs Market, by End-User
- 8.1. Introduction
- 8.2. Hospitals
- 8.3. Pharmaceutical & Biotechnology Companies
- 8.4. Research & Academic Institutions
9. Americas Marine Derived Drugs Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Marine Derived Drugs Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Marine Derived Drugs Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.3.1. UC San Diego Innovates Algae-Based Microbot Technology for Enhanced Lung Tumor Drug Delivery
- 12.3.2. GITAM secures INR 13.69 crore for innovative marine drug discovery center to combat cancer and antibiotic resistance
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Aker BioMarine ASA
- 2. Aphios Corporation
- 3. Eisai Co., Ltd.
- 4. Gimv NV
- 5. GlycoMar Limited
- 6. Marinova Pty Ltd.
- 7. Nereus Pharmaceuticals, Inc.
- 8. Perha Pharmaceuticals
- 9. Pfizer, Inc.
- 10. Pharma Mar, S.A.
- 11. TransAlgae
- 12. Zelnova Zeltia
LIST OF FIGURES
- FIGURE 1. MARINE DERIVED DRUGS MARKET RESEARCH PROCESS
- FIGURE 2. MARINE DERIVED DRUGS MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. MARINE DERIVED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. MARINE DERIVED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. MARINE DERIVED DRUGS MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. MARINE DERIVED DRUGS MARKET DYNAMICS
- TABLE 7. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ALGAE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY INVERTEBRATES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY MICROORGANISMS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-COAGULANTS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-MICROBIAL, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-VIRAL, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY ANTICANCER, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 19. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 20. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 21. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 22. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 23. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 24. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 25. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 26. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 27. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 28. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 29. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 30. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 31. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 32. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 33. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 34. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 35. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 36. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 37. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 38. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 39. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 40. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 41. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 42. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 43. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 44. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 45. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 46. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 47. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 48. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 49. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 50. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 51. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 52. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 53. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 54. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 55. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 56. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 57. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 58. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 59. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 60. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 61. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 62. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 63. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 64. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 65. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 66. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 67. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 68. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 69. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 70. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 71. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 72. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 73. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 74. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 75. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 76. THAILAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 77. THAILAND MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 78. THAILAND MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 79. VIETNAM MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 80. VIETNAM MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 81. VIETNAM MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 82. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 83. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 84. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 85. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 86. DENMARK MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 87. DENMARK MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 88. DENMARK MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 89. EGYPT MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 90. EGYPT MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 91. EGYPT MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 92. FINLAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 93. FINLAND MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 94. FINLAND MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 95. FRANCE MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 96. FRANCE MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 97. FRANCE MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 98. GERMANY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 99. GERMANY MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 100. GERMANY MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 101. ISRAEL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 102. ISRAEL MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 103. ISRAEL MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 104. ITALY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 105. ITALY MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 106. ITALY MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 107. NETHERLANDS MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 108. NETHERLANDS MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 109. NETHERLANDS MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 110. NIGERIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 111. NIGERIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 112. NIGERIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 113. NORWAY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 114. NORWAY MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 115. NORWAY MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 116. POLAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 117. POLAND MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 118. POLAND MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 119. QATAR MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 120. QATAR MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 121. QATAR MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 122. RUSSIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 123. RUSSIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 124. RUSSIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 125. SAUDI ARABIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 126. SAUDI ARABIA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 127. SAUDI ARABIA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 128. SOUTH AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 129. SOUTH AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 130. SOUTH AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 131. SPAIN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 132. SPAIN MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 133. SPAIN MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 134. SWEDEN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 135. SWEDEN MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 136. SWEDEN MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 137. SWITZERLAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 138. SWITZERLAND MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 139. SWITZERLAND MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 140. TURKEY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 141. TURKEY MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 142. TURKEY MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 143. UNITED ARAB EMIRATES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 144. UNITED ARAB EMIRATES MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 145. UNITED ARAB EMIRATES MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 146. UNITED KINGDOM MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
- TABLE 147. UNITED KINGDOM MARINE DERIVED DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
- TABLE 148. UNITED KINGDOM MARINE DERIVED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 149. MARINE DERIVED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 150. MARINE DERIVED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
